-
1. Clinical and experimental approaches for imaging of acute kidney injury. Clin Exp Nephrol. 2021 Jul;25(7):685-699.
Katagiri D, Wang F, Gore JC, Harris RC, Takahashi T.
-
2. Directhemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun;36(3):313-321.
Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H et al.
-
3. Evaluation of Coronavirus Disease Serity Using Urine Biomarkers. Crit Care Explor. 2020;2(8):e0170.
Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y et al.
-
4. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19. Blood purification. 2020:1-3.
Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T et al.
-
5. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int. 89(2): 374-85, 2016.
Katagiri D, Hamasaki Y, Doi K, Negishi K, Sugaya T, Nangaku M, Noiri E.
-
6. Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection. J Am Soc Nephrol. 24(12): 2034-43, 2013.
Katagiri D, Hamasaki Y, Doi K, Okamoto K, Negishi K, Nangaku M, Noiri E.
-
7. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. The Annals of thoracic surgery. 93(2): 577-83, 2012.
Katagiri D, Doi K, Honda K, Negishi K, Fujita T, Hisagi M, Ono M, Matsubara T, Yahagi N, Iwagami M, Ohtake T, Kobayashi S, Sugaya T, Noiri E.
-
8. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int. 82(10): 1114-20, 2012. (*Equally First Authour)
Doi K*, Katagiri D*, Negishi K, Hasegawa S, Hamasaki Y, Fujita T, Matsubara T, Ishii T, Yahagi N, Sugaya T, Noiri E.
-
9. For safe and adequate blood purification therapy in severe COVID-19 - what we have learned so far. Global Health & Medicine. Vol.4 (2), 94 -100. 2022
Katagiri D.
-
10. Adjuvant Diagnosis of Tuberculosis in Hemodialysis Patients Using Fourth Generation Interferon γ Releasing Assay. Ther Apher Dial. 2022 Oct 7. doi: 10.1111/1744-9987.13939. PMID:36205196.
Chinen M, Katagiri D, Sakamoto E, Noguchi H, Suzuki M, Kondo I, Niikura T, Arai Y, Suzuki M, Hinoshita F, Takano H.
-
11. A Case of severe generalized pustular psoriasis successfully treated with IL-17A monoclonal antibody and granulocyte removal therapy. Renal Replace Ther, 2022.
Shimada K, Katagiri D, Kato A, Nunose N, Sato M, Katayama Y, Terakawa K, Niikura T, Sakamoto E, Yoshizaki Y, Suzuki M, Fukaya T, Tamaki T, Takano H.
-
12. Efficacy and Safety of Direct Hemoperfusion using Polymyxin B-Immobilized Polystyrene Column (PMX-DHP) for COVID-19 Patients: Exploratory Study Protocol. JMIR Res Protoc. 2022 Sep 1. doi: 10.2196/37426. PMID: 36126219.
Terada-Hirashima J, Izumi S, Katagiri D, Uemura Y, Mikami A, Sugiura W, Abe S, Azuma A, Sugiyama H.
-
13. When should PMX-DHP be introduced to improve COVID-19 prognosis? Ther Apher Dial. 2022 Mar 5. doi: 10.1111/1744-9987.13825. Epub ahead of print. PMID: 35247232
Katagiri D, Izumi S, Takano H.
-
14. Safety of casirivimab/imdevimab administration in a SARS-CoV-2 positive maintenance dialysis patient in Japan. CEN Case Rep. 2022 Jan 9.PMID: 35000134.
Terakawa K, Katagiri D, Shimada K, Sato L, Takano H.
-
15. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul;27(7):1043-1050. PMID: 33865699
Yamada G, Hayakawa K, Katagiri D, et al.
-
16. Assessment of Renal Fibrosis in Murine Diabetic Nephropathy Using Quantitative Magnetization Transfer MRI. Magnetic Resonance in Medicine, 80(6): 2655-2669, 2018 (*Equally First Author)
Wang F*, Katagiri D*, Li K, Takahashi K, Wang S, Nagasaka S, Li H, Quarles C, Zhang MZ, Shimizu A, Gore JC, Harris RC, Takahashi T.
-
17. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome. CEN Case reports, 2018.
Katagiri D, Hinoshita F.
-
18. Human Peripheral Blood Mononuclear Cells Incubated in Vasculogenic Conditioning Medium Dramatically Improve Ischemia/Reperfusion Acute Kidney Injury in Mice. Cell Transplant. 27(3): 520-30, 2018.
Ohtake T, Kobayashi S, Slavin S, Mochida Y, Ishioka K, Moriya H, Hidaka S, Matsuura R, Sumida M, Katagiri D, Noiri E, Okada K, Mizuno H, Tanaka R.
-
19. Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis. Intern Med. 55(19): 2831-36, 2016.
Sugawara Y, Honda K, Katagiri D, Nakamura M, Kawakami T, Nasu R, Hayashi A, Tojo A, Noiri E, Kurokawa M, Fukayama M, Nangaku M.
-
20. Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney. Am J Pathol. 185(7): 1889-98, 2015.
Okamoto K, Honda K, Doi K, Ishizu T, Katagiri D, Wada T, Tomita K, Ohtake T, Kaneko T, Kobayashi S, Nangaku M, Tokunaga K, Noiri E.
-
21. Deep vein puncture under ultrasonographic guidance-an alternative approach for vascular access of apheresis therapies. Journal of clinical apheresis. 30(6): 380-1, 2015.
Hanafusa N, Torato T, Katagiri D, Usui T, Matsumoto A, Noiri E, Nangaku M.
-
22. New biomarker panel of plasma neutrophil gelatinase-associated lipocalin and endotoxin activity assay for detecting sepsis in acute kidney injury. Journal of critical care. 28(5): 564-70, 2013.
Katagiri D, Doi K, Matsubara T, Negishi K, Hamasaki Y, Nakamura K, Ishii Takeshi, Yahagi N, Noiri E.
-
23. A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1. Am J Physiol Renal Physiol. 305(12): F1796-803, 2013.
Hamasaki Y, Doi K, Maeda-Mamiya R, Ogasawara E, Katagiri D, Tanaka T, Yamamoto T, Sugaya T, Nangaku M, Noiri E.
-
24. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study. Crit Care. 17(6): R270, 2013.
Doi K, Urata M, Katagiri D, Inamori M, Murata S, Hisagi M, Ono M, Matsubara T, Ishii T, Yahagi N, Nangaku M, Noiri E.
-
25. Peritoneal findings from two patients with Takayasu arteritis on peritoneal dialysis. Peritoneal dialysis international. 31(4): 502-3, 2011
Katagiri D, Ishibashi Y, Kawarazaki C, Kume H, Fujita T.
-
26. Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis. Nephron Clinical practice. 117(1): c28-32, 2011.
Katagiri D, Hagiwara S, Minami E, Katsuma A, Masumoto S, Hoshino T, Inoue T, Shibata M, Tada M, Nakamura T, Shimbo T, Hinoshita F.
-
27. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Critical care medicine. 39(11): 2464-9, 2011.
Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, Yahagi N, Sugaya T, Noiri E.
-
28. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone. Clinical and Experimental Nephrology. 14(5): 501-5, 2010.
Katagiri D, Shibata M, Katsuki T, Masumoto S, Katsuma A, Minami E, Hoshino T, Inoue T, Tada M, Hinoshita F.
-
29. Positron emission tomography combined with computed tomography (PET-CT) as a new diagnostic tool for acute tubulointerstitial nephritis (AIN) in oliguric or haemodialysed patients. NDT plus. 3(2): 155-9, 2010.
Katagiri D, Masumoto S, Katsuma A, Minami E, Hoshino T, Inoue T, Shibata M, Tada M, Morooka M, Kubota K, Hinoshita F.
-
30. Large perinephric abscess in a patient on maintenance hemodialysis diagnosed by positron emission tomography combined with computed tomography (PET-CT). Clinical nephrology. 73(2): 163-6, 2010.
Katagiri D, Inoue T, Katsuma A, Masumoto S, Minami E, Hoshino T, Shibata M, Tada M, Nakamura T, Kubota K, Hinoshita F.
-
1. 2009年 2nd Congress of International Society for Hemodialysis, ISHD Best Presentation Award, Hong Kong, August 28, 2009.
-
2. 2013年 第27回 日本心臓財団・バイエル薬品 海外留学助成
-
3. 2014年 第57回 日本腎臓学会学術総会 会長賞
-
4. 2015年 日本学術振興会 海外特別研究員
-
5. 2016年 第45回 かなえ医薬振興財団 海外留学助成
-
6. 2016年 上原記念生命科学財団 海外留学助成リサーチフェローシップ
-
7. 2017年 Fellow of American Society of Nephrology
-
8. 2018年 National Institute of Diabetes and Digestive and Kidney Diseases(NIDDK)Scholarship, Keystone Symposia, Santa Fe, New Mexico, 2018
-
9. 2019年 国立国際医療研究センター 国際医療研究開発費(重点研究分野、研究代表者)
-
10. 2020年 AMED ウイルス等感染症対策技術開発事業(分担研究者)
-
11. 2021年 国立国際医療研究センター 国際医療研究開発費(重点研究分野、研究代表者)
-
12. 2021年 国立国際医療研究センター 箱根山奨励賞
-
13. 2021年 American Society for Apheresis(ASFA) Annual Speaker Spotlight
-
14. 2021年 医療技術等国際展開推進事業(研究代表者)
-
15. 2021年 国立国際医療研究センター 国際医療研究開発費(重点研究分野、研究代表者)
-
16. 2022年 Fellow of American College of Physicians
-
17. 2022年 Clinical Journal of Apheresis, Wiley Top Cited Article 2020‐2021.
-
18. 2022年 第65回 日本腎臓学会学術総会 優秀演題賞. 神戸. 2022/6/10-12.
-
19. 2022年 日本アフェレシス学会 2022年度 井上学術奨励賞